Intra-tumor and peritumoral radiomics and deep learning based on ultrasound for differentiating fibroadenoma and phyllodes tumor: a multicenter study [0.03%]
基于超声的肿瘤内和瘤周影像组学和深度学习区分纤维腺瘤和叶状肿瘤：多中心研究
Guoxiu Lu,Ronghui Tian,Wei Yang et al.
Guoxiu Lu et al.
Purpose: To develop and validate an integrated intra-tumoral (ITR) and peritumoral (PTR) radiomics-deep learning model based on ultrasound (US) imaging for accurately differentiating fibroadenomas (FA) from phyllodes tumo...
Global, regional, and national burden of 34 cancer groups across 204 countries and territories, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 [0.03%]
204个国家和领土1990年至2021年的34种癌症疾病负担及2050年预测：来自全球疾病负担研究（2021）的系统分析
Linfeng Zhu,Jiangpeng Zhu,Qing Wang et al.
Linfeng Zhu et al.
Introduction: Detailed, comprehensive, and timely reporting on cancer incidence, mortality, and associated burdens is essential for understanding the evolving trends of this complex disease. This study aims to evaluate th...
The CILLO-E Hypothesis: Erythrocyte-Driven Acidosis and Early Eryptosis as Drivers of Cancer-Associated Anemia [0.03%]
CILLO-E假说：红细胞驱动的酸中毒和早期血影形成是癌症相关性贫血的驱动因素
Hüseyin Aydın
Hüseyin Aydın
Background: The tumor microenvironment (TME) is characterized by high lactate and proton accumulation resulting from glycolytic metabolism. While acidosis is known to influence immune and stromal cells, its direct effects...
Real-world survival patterns and multimodal therapy utilization in small cell lung cancer: a retrospective cohort study in a Chinese countryside hospital [0.03%]
中国农村医院的小细胞肺癌患者的生存模式和多种治疗的使用情况：一项回顾性队列研究
Taosheng Huang,Linjie Ma,Mingfang Wang et al.
Taosheng Huang et al.
Introduction: Small cell lung cancer (SCLC) accounts for 13-15% of all lung malignancies and remains a highly aggressive disease with limited therapeutic progress, particularly in rural settings. Despite advances such as ...
Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy [0.03%]
病例报告：PBRM1失活的高级别 II 级脑膜瘤对免疫治疗有长期反应
Ellen Reusch,Keng Hee Peh,Rachael Morgan et al.
Ellen Reusch et al.
Meningiomas are the most common primary tumor in the central nervous system, yet an effective systemic treatment remains a challenge. We present a grade 2 meningioma that resulted in a positive and prolonged response to pembrolizumab. Our c...
Multidisciplinary management of intracardiac tumor thrombus in low-grade endometrial stromal sarcoma: case report and literature review [0.03%]
低级别子宫内膜间质肉瘤心脏内肿瘤栓的多学科治疗：病例报告与文献回顾
Hanke Zhang,Jinhua Chen,Chao Yang et al.
Hanke Zhang et al.
The low-grade endometrial stromal sarcoma (LG-ESS) represents a slowly proliferating subtype of endometrial stromal tumor but exhibits a preference for late-stage recurrence. Incidence of invasion into major blood vessels and the heart is e...
Inverse association between serum lipid profiles and hepatocellular carcinoma risk: a meta-analysis of epidemiological studies [0.03%]
基于流行病学研究的血清脂质谱与肝癌风险负相关的meta分析
Chongshi Zeng,Shuran Liu,Haining Li et al.
Chongshi Zeng et al.
background: The relationship between serum lipid profiles and hepatocellular carcinoma (HCC) risk remains controversial. We aimed to clarify this association through a systematic meta-analysis of epidemiological studies...
The influence of extraprostatic extension grade on the detection of pelvic lymph node metastasis in prostate cancer [0.03%]
前列腺癌患者移行带外浸润程度对盆腔淋巴结转移检测的影响分析
Jun-Guang Wang,Ling-Ling Ying,Pei-Pei He
Jun-Guang Wang
Introduction: This study was conducted to evaluate any association between extraprostatic extension (EPE) grade with the risk of pelvic lymph node metastasis (PLNM) of prostate cancer (PCa). ...
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab [0.03%]
不可切除非小细胞肺癌患者接受含度伐利尤单抗放化疗治疗时血液肿瘤突变负荷的生物标志物价值评估
Henrik Horndalsveen,Vilde Drageset Haakensen,Tesfaye Madebo et al.
Henrik Horndalsveen et al.
Introduction: Chemoradiotherapy followed by durvalumab is a potentially curative treatment for unresectable, locally advanced non-small cell lung cancer (NSCLC), but clinical outcomes remain highly variable. Identifying r...
Case Report: Analysis of short-term clinical efficacy of trilaciclib in patients with advanced lung neuroendocrine carcinoma undergoing chemotherapy [0.03%]
病例报告：分析三贝妥短期临床疗效：三贝妥联合化疗治疗晚期肺神经内分泌癌患者的短期临床疗效分析
Yan Zeng,Nan Lin
Yan Zeng
Lung neuroendocrine carcinoma is a rare heterogeneous tumor with the characteristics of high invasiveness, low incidence, and poor survival prognosis. Currently, there is a lack of effective treatment measures, and treatment strategies are ...